Scalp Nerve Block and Opioid Consumption in Brain Surgery
- Conditions
- Brain Tumour
- Interventions
- Drug: Scalp block with 0.5% plain MarcaineDrug: Scalp block with 0.9% normal saline
- Registration Number
- NCT02057367
- Lead Sponsor
- Chiang Mai University
- Brief Summary
Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).
- Detailed Description
Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).
A Prospective Randomized Double Blind Control
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Patients who have supratentorial brain tumor
- Patients have been scheduled to undergo an elective craniotomy to remove tumor in any surgical position
- Patients have been general anesthetized with endotracheal intubation and control ventilation
- Patients who have provided consent for the participation in the research and for the use of their medical record in research
- Pregnant patients
- Patients who have a history of local anesthetic allergy and/ or anaphylaxis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Scalp block with 0.5% plain marcaine Scalp block with 0.5% plain Marcaine Anterior scalp block with 0.5% plain Marcaine 20 ml. Scalp block with 0.9% normal saline Scalp block with 0.9% normal saline Anterior scalp block with 0.9% normal saline 20 ml.
- Primary Outcome Measures
Name Time Method Intraoperative opioid consumption During the supratentorial craniotomy surgery The overall intravenous fentanyl consumption (microgram/ kilogram) during the surgery. The decision to administer fentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.
- Secondary Outcome Measures
Name Time Method Heart rate change within 5 minutes after skull pin insertion The maximal heart rate within the first 5 minutes after skull pin insertion will be recorded.
The heart rate change from baseline level will be calculated. The unit is beats per minute.systolic blood pressure change within 5 minutes after skull pin insertion The maximal systolic blood pressure within the first 5 minutes after skull pin insertion will be recorded.
The systolic blood pressure change from baseline will be calculated. The unit is mmHg.
Trial Locations
- Locations (1)
Chiang Mai University
🇹ðŸ‡Chiang Mai, Thailand